Gunung Raja Paksi Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Gunung Raja Paksi Tbk. trades at Rp294 (market cap 3.58T, 527.5K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 51K 24h volume). The key difference: Gunung Raja Paksi Tbk. is far larger — about 21.4× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Gunung Raja Paksi Tbk. is more actively traded (527.5K versus 51K). Which is the better fit depends on your goals.
| GGRP | OBAT | |
|---|---|---|
Market Cap | 3.58T | 167.37B |
Volume | 527.5K | 51K |
Lot | 5.28K | 510 |
Turnover | 154.61M | 12.55M |
Average Price | 293.1 | 246.09 |
Value | 154.61M | 12.55M |
Indicative Equilibrium Price | 296 | 246 |
Indicative Equilibrium Volume | 300 | 2.4K |
Trailing returns across standard periods
Latest headlines on both assets
PT. Gunung Raja Paksi Tbk (the Company) was established under the name of PT Gunung Naga Mas based on Notarial Deed No.229 of Chairani Bustami,S.H. dated August 20,1990 that was amended by Notarial Deed No.25 dated June 6,1991. The change from Foreign Capital Investment (“FCI”) to Domestic Capital Investment (“DCI”) has been approved by the Capital Investment Coordinating Board of the Republic of Indonesia in its Letter No.346/1/IP/PMDN/2016 dated December 15, 2016.
Read more on GGRP →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →